This compound is a deuterated pharmaceutical intermediate, specifically a trideuteriomethoxy-substituted carbamate derivative. It is used in the manufacturing of pharmaceuticals where deuterium incorporation is desired.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1346600-86-9
(²H₅)Phenyl(²H₂)methanol
pharmaceutical intermediate
N,N-Bis[(²H₃)methyl](²H₃)acetamide
pharmaceutical intermediate
1-Adamantan-D15-amine
pharmaceutical intermediate
Iodoethane-d5
pharmaceutical intermediate
5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide
pharmaceutical intermediate
3-Amino-4-(2-chlorophenyl)-6-nitro-2(1H)-quinolinone
pharmaceutical intermediate
3-Amino-6-chloro-4-(4-pyridinyl)-2-quinolinone Hydrazone
pharmaceutical intermediate
(2R,3S)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid
pharmaceutical intermediate
[2-hydroxy-3-[2-(trideuteriomethoxy)phenoxy]propyl] carbamate
GNXFOGHNGIVQEH-FIBGUPNXSA-N
[2H]C([2H])([2H])OC1=CC=CC=C1OCC(COC(=O)N)O
—